false
0000050471
0000050471
2026-11-13
2026-11-13
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): November 13, 2026
REPOSITRAK, INC.
(Exact name of Registrant as specified in its Charter)
|
Nevada
|
001-34941
|
37-1454128
|
|
(State or other jurisdiction of
incorporation)
|
(Commission File No.)
|
(IRS Employer Identification No.)
|
5282 South Commerce Drive, Suite D292,Murray,Utah 84107
(Address of principal executive offices)
(435)645-2000
(Registrant’s Telephone Number)
Not Applicable
(Former name or address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
|
☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
☐
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
☐
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
☐
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Securities registered pursuant to Section 12(b) of the Act:
|
Title of each class
|
Trading Symbol(s)
|
Name of exchange on which
registered
|
|
Common stock, par value $0.01 per share
|
TRAK
|
New York Stock Exchange
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR 230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR 240.12b-2)
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
|
Item 1.01
|
Entry into a Material Definitive Agreement.
|
Note and Common Stock Exchanges.
On November 13, 2026, ReposiTrak, Inc. (the “Company”) entered into an Exchange Agreement (the “Exchange Agreement”) with SPAR Group, Inc., a Delaware corporation (“SPAR”), SPAR Marketing Force Inc., a wholly owned subsidiary of SPAR (“SPM”), and PC Group, Inc., a wholly owned subsidiary of the Company (“PCG”). Pursuant to the Exchange Agreement, PCG agreed to exchange all outstanding principal and accrued interest under its promissory note receivable from SPAR (“Note”), totaling approximately $4.0 million (the “Note Exchange”), for shares of SPAR’s Series C Convertible Preferred Stock, par value $0.01 per share (the “Series C Preferred”), having a stated value of $1,000 per share (“Stated Value”). The Series C Preferred (i) is convertible into Common Stock at $0.38 per share (“Conversion Price”), (ii) pays cumulative dividends at 8% per annum, payable quarterly in cash, with an additional 2% per annum if paid in additional shares of Series C Preferred, (iii) is senior to all other equity, equal to the Stated Value plus accrued but unpaid dividends, and (iv) votes together with the Common Stock on an as-converted basis, subject to the Beneficial Ownership Limitation, defined below. The Company may also exchange other amounts due and owing it by SPAR (“Future Obligations”), currently totaling approximately $1.1 million, for additional shares of Series C Preferred.
In addition, the Company and PCG agreed to exchange their aggregate holdings of 8,900,406 shares of SPAR common stock, par value $0.01 per share (the “Common Stock”), for 3,360 shares of Series C Preferred, representing an agreed aggregate exchange value of $3,359,605 (the “Common Exchange” and, together with the Note Exchange, the “Exchanges”). As additional consideration for the Exchanges, SPAR agreed to issue the Company a single warrant to purchase an aggregate of 9,684,211 shares of Common Stock at an exercise price of $0.38 per share (the “Warrant”). Upon consummation of the Exchanges, the Note and the 8,900,406 shares of Common Stock were cancelled. Warrants similarly have an exercise price equal to the Conversion Price and are exercisable beginning January 31, 2028 with a four-year term, expiring January 31, 2032.
The Series C Preferred and Warrants are subject to beneficial ownership limitations whereby they shall not be exercisable, and the Series C Preferred cannot be converted, to the extent their exercise or conversion, as the case may be, would cause the beneficial ownership of Common Stock held by the Company to exceed 50% of the total issued and outstanding shares of Common Stock (“Beneficial Ownership Limitation”). The Beneficial Ownership Limitation expires on December 23, 2027, after which date the Company’s beneficial ownership could exceed 50% upon conversion of Series C Preferred or exercise of Warrants.
The Exchange Agreement also provides for the Company to indemnify SPAR and its officers and directors against any claims arising out of the Exchanges after SPAR’s directors and officers’ insurance and charter indemnification have been exhausted.
Revolving Credit Agreement.
In connection with the Exchanges, the Company entered into a Revolving Credit Agreement with SPAR on November 13, 2026 (the “Credit Agreement”), providing for a revolving credit facility of up to $1.5 million (the “Line of Credit”). The Company may satisfy its commitment through direct advances, credit support for financing provided by third-party lenders, or a combination thereof, subject to the terms of the Credit Agreement. Outstanding direct advances bear interest at 8% per annum, payable monthly in cash, with an additional 2% per annum during the continuance of an event of default. The Line of Credit matures on November 13, 2028, subject to adjustment to the next business day (the “Maturity Date”).
At the Maturity Date or following acceleration of the outstanding balance, the Company may, at its sole election, require repayment of outstanding principal in cash, convert all or a portion of such principal into Series C Preferred at its Stated Value, or elect a combination of cash repayment and conversion. SPAR has no right to require or reject a conversion validly elected by the Company. Accrued and unpaid interest remains payable in cash unless otherwise agreed in writing.
As additional consideration for the Line of Credit, SPAR is obligated to issue warrants to the Company in connection with qualifying direct advances, providing 50% warrant coverage based on the Conversion Price (the “Conversion Warrants”), regardless of whether the underlying principal is subsequently converted. The Conversion Warrants have an exercise price of $0.38 per share, are not exercisable before the later of January 31, 2028 and their issuance date, and have a four-year term commencing on that date.
The Credit Agreement also provides that, if the Company arranges or procures qualifying third-party financing for SPAR or its subsidiaries (“Sourced Financing”), the Company will receive additional Series C Preferred (the “Sourcing Shares”) and warrants providing 50% coverage (the “Sourcing Warrants”). Such consideration is determined by reference to the qualifying financing commitment, subject to an aggregate $1.5 million limitation and provisions preventing duplicative warrant coverage. The Sourcing Shares and Sourcing Warrants are issuable in accordance with the Credit Agreement regardless of whether the third-party financing is fully drawn.
For so long as the Company holds Series C Preferred, if SPAR issues Common Stock or securities convertible into or exercisable for Common Stock, SPAR must issue the Company additional shares of Series C Preferred so that the Company's as-converted percentage ownership of SPAR remains unchanged. This protection also applies to issuances to the Company, including Series C Preferred issued under the Credit Agreement, as dividends or in exchange for Future Obligations; Common Stock issued on conversion of the Series C Preferred or exercise of the Warrants; and the additional anti-dilution shares themselves.
The foregoing descriptions of the Exchange Agreement, Credit Agreement and form of Warrant do not purport to be complete and are qualified in their entirety by reference to the full text of the Exchange Agreement, Credit Agreement and form of Warrant filed as Exhibit 10.1, 10.2 and 10.3, respectively, to this Current Report on Form 8-K, and incorporated by reference herein.
The disclosure contained in Item 1.01 of this Current Report on Form 8-K is incorporated herein by reference.
|
Item 9.01
|
Financial Statements and Exhibits.
|
(d) Exhibits
|
Exhibit
Number
|
|
Description
|
| |
|
|
|
10.1
|
|
Exchange Agreement dated November 13, 2026 by and between SPAR Group, Inc. and the Company
|
|
10.2
|
|
Revolving Credit Agreement dated November 13, 2026 by and between SPAR Group, Inc. and the Company
|
|
10.3
|
|
Form of Warrants
|
|
104
|
|
Cover Page Interactive Data File (embedded within the Inline XBRL document)
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| |
REPOSITRAK, INC.
|
| |
|
|
Date: November 17, 2026
|
/s/ John Merrill
|
| |
John Merrill
|
| |
Chief Financial Officer
|